Armata Pharmaceuticals, Inc. (ARMP)

Armata Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	93	117	45	148	56	32
Market Cap Growth	150.33%	161.30%	-69.80%	165.90%	72.90%	376.09%
Enterprise Value	217	218	73	175	58	28
PE Ratio	-	-1.70	-1.21	-6.41	-2.52	-1.66
PS Ratio	19.70	25.86	8.14	33.18	67.83	-
PB Ratio	-2.67	-3.65	1.24	5.85	2.96	2.21
P/FCF Ratio	-3.23	-2.11	-1.29	-5.97	-2.92	-2.05
P/OCF Ratio	-3.74	-2.47	-1.38	-6.30	-3.06	-2.07
EV/Sales Ratio	46.21	48.19	13.22	39.10	70.62	-
EV/EBITDA Ratio	-3.72	-3.33	-2.02	-7.98	-2.84	-1.65
EV/EBIT Ratio	-3.67	-3.29	-1.97	-7.58	-2.70	-1.53
EV/FCF Ratio	-5.89	-3.93	-2.10	-7.03	-3.04	-1.81
Debt / Equity Ratio	-2.97	-3.75	1.35	1.50	0.70	0.20
Debt / EBITDA Ratio	-2.27	-1.84	-1.36	-1.73	-0.64	-0.17
Debt / FCF Ratio	-3.59	-2.17	-1.41	-1.53	-0.69	-0.18
Quick Ratio	0.41	1.37	1.18	2.39	1.62	1.38
Current Ratio	0.38	1.16	1.09	3.12	1.62	1.36
Asset Turnover	0.04	0.04	0.06	0.08	0.02	0
Interest Coverage	-16.90	-25.29	-	-360.80	-34.32	-19.92
Return on Equity (ROE)	389.00%	9653.30%	-75.20%	-82.90%	-83.20%	-129.20%
Return on Assets (ROA)	-73.60%	-65.60%	-37.20%	-43.40%	-49.60%	-78.50%
Return on Capital (ROIC)	-35.70%	-46.30%	-43.52%	-37.58%	-67.44%	-113.15%
Earnings Yield	-85.98%	-58.95%	-82.37%	-15.60%	-39.73%	-60.33%
FCF Yield	-50.58%	-47.44%	-77.40%	-16.76%	-34.20%	-48.67%
Buyback Yield / Dilution	-0.22%	-5.19%	-42.27%	-46.84%	-104.93%	-72.15%
Total Shareholder Return	-0.22%	-5.19%	-42.27%	-46.84%	-104.93%	-72.15%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).